AF
ERAS icon

Amalgamated Financial’s Erasca ERAS Stock Holding History

Amalgamated Financial’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$64K Buy
+7,441
New +$86.2K ﹤0.01% 2306

Other funds holding ERAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Amalgamated Financial's ERAS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Erasca (ERAS) in Q1 2022: 7,441 shares worth $64K. The stake represents ﹤0.01% of the portfolio and ranks #2306 among its holdings.

82 funds tracked by Wall St. Rank hold ERAS as of Q1 2022.

  • Amalgamated Financial held 7,441 shares of Erasca worth $64K as of Q1 2022.
  • Erasca was a new Amalgamated Financial position in Q1 2022.
  • Erasca made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2306 holding.
  • 82 funds tracked by Wall St. Rank held Erasca as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.